We propose that our dose-titrating systems can model a non-linear OIS spectrum, including senescence intermediates such as slow-cycling (RPE1 cells) and immune-resistant tumour-initiating states (mouse livers), both characterized by increased progenitor features and a reduced MYC signature. Here, MYC is linked to neoplasm.